The gelling fbre dressing you would design

Easy removal Superior fuid retention Rapid antimicrobial action Breaks down bioflm

Applicable to Exufberreg Ag+ only

We discovered ldquoWe went through hundreds of prototypes

before arriving at the fnal design that gelling fbre The clinical results proved that we had created something specialrdquo

Erik Carlsson Moumllnlycke Research amp Development dressings could perform even better At Moumllnlyckereg we have carried out a multinational survey asking more than 500 clinicians about their day to day challenges when treating wounds with gelling fbre dressings The results show that current alternatives leave much to be desired

said their current said that managing gelling fbre More leakage and

More than dressing broke up maceration were during removal1 than half key challenges1

1 in 3

Exudate management is a balancing act When it comes to exudate management gelling fbre dressings must do more than absorb fuid They must also retain that fuid when compressed Otherwise fuid could leak out and cause moisture-related skin damage

Gelling fbre dressings must balance these four characteristics

Absorption

Wet strength

Fluid retention

Conformability

Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage

Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10

High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7

bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only

Reduced risk of skin damage2ndash3 Hydrolockreg

Leakage can lead to skin damage such as 100

Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the

dressing is compressed 90

85

80

75

70

65

60

Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5

r

eten

tion

Gelling fbre dressings reinvented

Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a

Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing

The silver effect Exufber Ag+ contains fne

silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver

ions that work against pathogens

Bacterial counts (CFU) 10

of Pseudomonas 9

aeruginosa bioflm 8 after treatment9

7

Exufberreg Ag+

Log

CF

Ug

6

5

4

3

Baseline Day 3 Day 5 Day 7

Aquacelreg gelling fbre dressing

Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration

2 Aquacelreg Ag+ Extra

1

Untreated control 0

Superior antibioflm action

Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9

chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only

Exufberreg gelling fbre dressing

with Hydrolockreg Technology with Hydrolockreg Technology

The gelling fbre dressings you would design

Superior retention458 Antimicrobial action against broad range of

Easy removal2 pathogens including VRE MRSA and mould68

Sustained antimicrobial action68 Breaks down bioflm in vivo9

May reduce odour10

Tested in vitro and applicable for Exufber Ag+ only

Exufber Ag+ ordering information Exufber ordering information

Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont

603421 5 x 5 10 40 603300 5 x 5 10 40

603425 10 x 10 10 60 603301 10 x 10 10 60

603422 10 x 12 10 60 603302 15 x 15 10 60

603423 15 x 15 10 60 603303 20 x 30 5 20

603424 20 x 30 5 20 603304 2 x 50 5 20

603420 2 x 45 5 20

REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm

Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007

Aquacelreg is registered trademark of ConvaTec Inc

We discovered ldquoWe went through hundreds of prototypes

before arriving at the fnal design that gelling fbre The clinical results proved that we had created something specialrdquo

Erik Carlsson Moumllnlycke Research amp Development dressings could perform even better At Moumllnlyckereg we have carried out a multinational survey asking more than 500 clinicians about their day to day challenges when treating wounds with gelling fbre dressings The results show that current alternatives leave much to be desired

said their current said that managing gelling fbre More leakage and

More than dressing broke up maceration were during removal1 than half key challenges1

1 in 3

Exudate management is a balancing act When it comes to exudate management gelling fbre dressings must do more than absorb fuid They must also retain that fuid when compressed Otherwise fuid could leak out and cause moisture-related skin damage

Gelling fbre dressings must balance these four characteristics

Absorption

Wet strength

Fluid retention

Conformability

Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage

Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10

High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7

bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only

Reduced risk of skin damage2ndash3 Hydrolockreg

Leakage can lead to skin damage such as 100

Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the

dressing is compressed 90

85

80

75

70

65

60

Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5

r

eten

tion

Gelling fbre dressings reinvented

Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a

Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing

The silver effect Exufber Ag+ contains fne

silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver

ions that work against pathogens

Bacterial counts (CFU) 10

of Pseudomonas 9

aeruginosa bioflm 8 after treatment9

7

Exufberreg Ag+

Log

CF

Ug

6

5

4

3

Baseline Day 3 Day 5 Day 7

Aquacelreg gelling fbre dressing

Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration

2 Aquacelreg Ag+ Extra

1

Untreated control 0

Superior antibioflm action

Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9

chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only

Exufberreg gelling fbre dressing

with Hydrolockreg Technology with Hydrolockreg Technology

The gelling fbre dressings you would design

Superior retention458 Antimicrobial action against broad range of

Easy removal2 pathogens including VRE MRSA and mould68

Sustained antimicrobial action68 Breaks down bioflm in vivo9

May reduce odour10

Tested in vitro and applicable for Exufber Ag+ only

Exufber Ag+ ordering information Exufber ordering information

Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont

603421 5 x 5 10 40 603300 5 x 5 10 40

603425 10 x 10 10 60 603301 10 x 10 10 60

603422 10 x 12 10 60 603302 15 x 15 10 60

603423 15 x 15 10 60 603303 20 x 30 5 20

603424 20 x 30 5 20 603304 2 x 50 5 20

603420 2 x 45 5 20

REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm

Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007

Aquacelreg is registered trademark of ConvaTec Inc

Exufberregrange The gelling fbre dressings you would design Combining antimicrobial action with clean easy removal and reduced risk of skin damage

Clean easy removal2 Reduced risk of skin damage3 Reduced risk of infection6ndash10

High wet tensile strength means the dressings Leakage can lead to skin damage such as maceration bull Provides rapid antimicrobial action that lasts up to 7 days (in vitro)6 stay intact on removal leaving no dressing Exufberrsquos superior retention45 reduces the risk of bull Works against a broad range of pathogens including VRE and MRSA (in vitro)6 residue in the wound bed leakage even when the dressing is compressed bull Provides an effective barrier against bacterial penetration (in vitro)7

bull Proven to kill 99 of mould within 24 hours (in vitro)8 bull Effective against bioflm9 bull May reduce odour10 Applicable to Exufber Ag+ only

Reduced risk of skin damage2ndash3 Hydrolockreg

Leakage can lead to skin damage such as 100

Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the

dressing is compressed 90

85

80

75

70

65

60

Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5

r

eten

tion

Gelling fbre dressings reinvented

Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a

Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing

The silver effect Exufber Ag+ contains fne

silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver

ions that work against pathogens

Bacterial counts (CFU) 10

of Pseudomonas 9

aeruginosa bioflm 8 after treatment9

7

Exufberreg Ag+

Log

CF

Ug

6

5

4

3

Baseline Day 3 Day 5 Day 7

Aquacelreg gelling fbre dressing

Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration

2 Aquacelreg Ag+ Extra

1

Untreated control 0

Superior antibioflm action

Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9

chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only

Exufberreg gelling fbre dressing

with Hydrolockreg Technology with Hydrolockreg Technology

The gelling fbre dressings you would design

Superior retention458 Antimicrobial action against broad range of

Easy removal2 pathogens including VRE MRSA and mould68

Sustained antimicrobial action68 Breaks down bioflm in vivo9

May reduce odour10

Tested in vitro and applicable for Exufber Ag+ only

Exufber Ag+ ordering information Exufber ordering information

Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont

603421 5 x 5 10 40 603300 5 x 5 10 40

603425 10 x 10 10 60 603301 10 x 10 10 60

603422 10 x 12 10 60 603302 15 x 15 10 60

603423 15 x 15 10 60 603303 20 x 30 5 20

603424 20 x 30 5 20 603304 2 x 50 5 20

603420 2 x 45 5 20

REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm

Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007

Aquacelreg is registered trademark of ConvaTec Inc

Reduced risk of skin damage2ndash3 Hydrolockreg

Leakage can lead to skin damage such as 100

Technology maceration Exufberrsquos superior retention 95reduces the risk of leakage even when the

dressing is compressed 90

85

80

75

70

65

60

Exufberreg dressings retain 23 more fuid than Aquacelreg Ag Extra5

r

eten

tion

Gelling fbre dressings reinvented

Exufber dressings are made using a patented processing method with a different material from traditional gelling fbres This is Hydrolockreg Technology locking in fuid and harmful bacteria and balancing the key features you expect in a

Aquacelreg Ag Extra Exufberreg Ag+ gelling fbre dressing

The silver effect Exufber Ag+ contains fne

silver sulphate that is evenly distributed in the dressing Contact with fuid initiates a controlled release of silver

ions that work against pathogens

Bacterial counts (CFU) 10

of Pseudomonas 9

aeruginosa bioflm 8 after treatment9

7

Exufberreg Ag+

Log

CF

Ug

6

5

4

3

Baseline Day 3 Day 5 Day 7

Aquacelreg gelling fbre dressing

Viewed under a microscope you can see that Exufber dressing is packed full of tightly entangled fbres that minimize the free space for fuid or exudate to fow which in turn boosts the entire dressingrsquos integrity The result is excellent tensile strength for easy removal and superior fuid retention to minimize the risk of leakage and maceration

2 Aquacelreg Ag+ Extra

1

Untreated control 0

Superior antibioflm action

Bioflms are clusters of bacteria that are resistant to prevent healing11 In vivo data shows that Exufber Ag+ treatment and the bodyrsquos natural defences It has been is signifcantly better at breaking down bioflm shown that bioflm may be present in up to 100 of compared to Aquacelreg Ag+ Extra9

chronic wounds and that bioflm may delay or even Applicable to Exufber Ag+ only

Exufberreg gelling fbre dressing

with Hydrolockreg Technology with Hydrolockreg Technology

The gelling fbre dressings you would design

Superior retention458 Antimicrobial action against broad range of

Easy removal2 pathogens including VRE MRSA and mould68

Sustained antimicrobial action68 Breaks down bioflm in vivo9

May reduce odour10

Tested in vitro and applicable for Exufber Ag+ only

Exufber Ag+ ordering information Exufber ordering information

Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont

603421 5 x 5 10 40 603300 5 x 5 10 40

603425 10 x 10 10 60 603301 10 x 10 10 60

603422 10 x 12 10 60 603302 15 x 15 10 60

603423 15 x 15 10 60 603303 20 x 30 5 20

603424 20 x 30 5 20 603304 2 x 50 5 20

603420 2 x 45 5 20

REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm

Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007

Aquacelreg is registered trademark of ConvaTec Inc

with Hydrolockreg Technology with Hydrolockreg Technology

The gelling fbre dressings you would design

Superior retention458 Antimicrobial action against broad range of

Easy removal2 pathogens including VRE MRSA and mould68

Sustained antimicrobial action68 Breaks down bioflm in vivo9

May reduce odour10

Tested in vitro and applicable for Exufber Ag+ only

Exufber Ag+ ordering information Exufber ordering information

Pcsshelf Pcstransp Pcsshelf Pcstransp Art no Size cm Art no Size cmcont cont cont cont

603421 5 x 5 10 40 603300 5 x 5 10 40

603425 10 x 10 10 60 603301 10 x 10 10 60

603422 10 x 12 10 60 603302 15 x 15 10 60

603423 15 x 15 10 60 603303 20 x 30 5 20

603424 20 x 30 5 20 603304 2 x 50 5 20

603420 2 x 45 5 20

REFERENCES 1 Moumllnlycke Health Care data Veeva Survey undertaken in UK Sweden Denmark Finland Norway and Latvia between September 2014 and July 2015 2 Chadwick P McCardle J Open non-comparative multi-centre post clinical study of the performance and safety of the gelling fbre wound dressing on diabetic foot ulcers Journal of Wound Care 2016 25(4) 290-300 3 Smet S Beele H Saine L Suys E Henrickx B Open non-comparative multi-centre post market clinical follow-up investigation to evaluate performance and safety on pressure ulcers when using a gelling fbre dressing as intended Poster Presentation at European Pressure Ulcer Advisory Panel Conference 2015 Ghent Belgium 4 Surgical Materials Testing Laboratory Method TM-404 Free Swell Absorption and Retention Report 20140806-001 (unpublished) 5 Moumllnlycke Health Care Laboratory Report PD-520425 (unpublished) 6 Molnlycke Health Care Laboratory Report 20160104-002 (unpublished) 7 Molnlycke Health Care Laboratory Report 20160621-001 (unpublished) 8 Molnlycke Health Care Laboratory Report 20160818-001 (unpublished) 9 Data on fle 10 Exufber Ag+ Instructions for use 11 WUWHS position report Management of Bioflm

Find out more at wwwmolnlyckeae Moumllnlycke Health Care AB P Box 212 565 Dubai UAE Phone +971 4 554 7317 The Moumllnlyckereg Exufberreg and Hydrolockreg trademarks names and logotypes are registered globally to one or more of the Moumllnlycke Health Care Group of Companies copy 2017 Moumllnlycke Health Care AB All rights reserved MEA 0007

Aquacelreg is registered trademark of ConvaTec Inc